| 000 | 01400 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512203134.0 | ||
| 264 | 0 | _c19840503 | |
| 008 | 198405s 0 0 eng d | ||
| 022 | _a0361-5960 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArdalan, B | |
| 245 | 0 | 0 |
_aPhase I study of continuous-infusion PALA and 5-FU. _h[electronic resource] |
| 260 |
_bCancer treatment reports _cMar 1984 |
||
| 300 |
_a531-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAspartate Carbamoyltransferase _xblood |
| 650 | 0 | 4 |
_aAspartic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDiarrhea _xchemically induced |
| 650 | 0 | 4 |
_aDigestive System _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Eruptions |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xblood |
| 650 | 0 | 4 |
_aPhosphonoacetic Acid _xadministration & dosage |
| 700 | 1 | _aJamin, D | |
| 700 | 1 | _aJayaram, H N | |
| 700 | 1 | _aPresant, C A | |
| 773 | 0 |
_tCancer treatment reports _gvol. 68 _gno. 3 _gp. 531-4 |
|
| 999 |
_c6231082 _d6231082 |
||